Home›Companies›Healthcare›Avkin

Avkin, Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 6, 2024·Suggest an edit

About Avkin

Avkin is a private company based in Wilmington, Delaware. It has reported $2,565,000 raised in four offerings on Form D since May 2017. Its chief executive is Amy Cowperthwait.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 25, 2024Dec 6, 2024$300,000fully sold1$300KDebt, Options, Securities on exerciseRule 506(b)Form D ↗
Nov 1, 2022Nov 10, 2022$900,000of $1.5M target1$900KEquityRule 506(b)Form D ↗
Apr 12, 2022Apr 20, 2022$615,000of $625K target2$307KDebt, Options, Securities on exerciseRule 506(b)Form D ↗
Apr 19, 2017May 3, 2017$750,000fully sold6$125KEquity, Securities on exerciseRule 506(b)Form D ↗
Total, four offerings$2,565,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Avkin's Form D filed Dec 6, 2024.

AC
Amy Cowperthwait
CEO and director

Earlier filings also listed John Martinson (director, last listed Nov 2022), David Broussard (director, last listed Nov 2022), Amy Erol (executive officer and director, last listed Nov 2022), Amy Bucha (executive officer and director, last listed Apr 2022) and Michael Patterson (coo and vp, director, last listed May 2017).

Sources

  1. SECAvkin, Inc. filing history